Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma
- Miguel, A.
- Sendra, L.
- Noé, V.
- Ciudad, C.J.
- Dasí, F.
- Hervas, D.
- Herrero, M.J.
- Aliño, S.F.
Revue:
OncoTargets and Therapy
ISSN: 1178-6930
Année de publication: 2017
Volumen: 10
Pages: 503-514
Type: Article
